Latest Medtech News
Inovus Medical, a UK-based surgical training technology company headquartered in St Helens, has extended its total funding raised to $20 million (reported elsewhere as approximately £15 million), backed by new investment from PXN Ventures and Unorthodox Ventures, alongside continued support from existing investor Mercia Ventures. The round is anchored by investment from the Liverpool City Region Life Science Innovation Zone.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like this one. Subscribe to our Industry Insights for weekly coverage.
The company said the funding will accelerate its growth across the US, support expansion into new international markets, grow its team, and extend its technology into additional surgical specialties, including flexible endoscopy, robotic surgery, and advanced hydrogel tissue simulation. Inovus's surgical training technology is already deployed across nearly 300 residency programs in the US.
Founded in 2012, Inovus builds hybrid surgical simulators that combine physical models with digital technology, alongside its Totum platform for tracking training data and performance metrics. The company has previously partnered with organizations including the NHS, the Royal College of Surgeons England, and the American Association of Gynecologic Laparoscopists, and reports its technology is used in more than 60% of NHS trusts and sold in over 70 countries.
For Inovus, the raise supports a broader push to move surgical education beyond traditional apprenticeship-based training models toward more repeatable, data-connected simulation. For the broader MedTech space, it reflects continued investment in surgical education infrastructure, an area gaining attention as healthcare systems look for scalable, standardized ways to train surgeons across an expanding range of procedures and specialties.
